BG Medicine Inc. (BGMD) announced after the bell Wednesday that the first automated version of the BGM Galectin-3 blood test has obtained a CE Mark. The stock is now up 0.33 on 36K shares.
BG Medicine was range-bound throughout Wednesday's session and closed up by 0.01 at $2.32. The stock has been losing ground for the last 2 1/2 weeks.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org